pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Jul 23·1 min read
save

Biopharma firms must prioritize hiring and retaining commercial talent for successful drug launches

Jul 23, 2026·read at BioSpace ↗Neutral

A BioSpace webinar brought together commercial leaders and a recruiting specialist to discuss how biopharma companies can better hire and keep commercial staff as they prepare for new product launches.

Job posting data from BioSpace shows a 38% year-over-year rise in sales, marketing and medical affairs positions in the past month, reflecting growing demand for launch-support roles.

Speakers noted that high demand gives candidates leverage, so firms must move quickly and respect candidates’ time. Amplity’s Margaret Blackwell said companies that streamline hiring and treat candidates as partners are more likely to secure top talent.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Make or break: Commercial hires critical for success”

read at BioSpace ↗
865 words · retrieved Jul 23
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COEli Lilly and CoLILLYPFIZERSEAGENUltragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
Oncology2Big PharmaRare Disease

related stories

  • 1h agoEyepoint, Enlivex enact heavy layoffsBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • Oct 75 biggest venture capital raises of Q3 2026BioSpace
  • Sep 17Chutes & Ladders—Legend poaches Novartis vet to boost commercial potentialFierce Biotech
  • Sep 2Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN dealsBioSpace